Skip to content
Inciteful Med

Introduction to 22q11.2 Deletion Syndrome

Published: | Updated:

22q11.2 Deletion Syndrome is a common, manageable genetic condition caused by a missing piece of chromosome 22. Formerly known as DiGeorge or Velocardiofacial syndrome, it affects everyone differently. Most cases occur by chance, and established medical guidelines exist to help guide care.

Key Takeaways

  • • 22q11.2 Deletion Syndrome is caused by a small missing piece on the 22nd chromosome.
  • • The condition is highly variable, meaning symptoms range from very mild to more complex even within the same family.
  • • Historical names like DiGeorge Syndrome and Velocardiofacial Syndrome (VCFS) describe the exact same genetic condition.
  • • Approximately 90% of cases occur by chance (de novo) and are not inherited from a parent.
  • • With established clinical guidelines and a multidisciplinary care team, it is a highly manageable condition.

Receiving a diagnosis of 22q11.2 deletion syndrome (22q11.2DS) often brings a mix of relief at finally having an answer and overwhelm at the road ahead. It is important to know that you are not alone; while the name may be new to you, this is one of the most common genetic conditions [1]. Every person with 22q11.2DS is unique, and while the syndrome can affect many parts of the body, it is a manageable condition with the right support system in place [2][3]. With proper care, individuals with 22q11.2DS can achieve a high quality of life and live full, meaningful lives [2].

One Condition, Many Names

In the past, you may have heard this condition referred to by several different names. Historically, doctors identified groups of symptoms and named them after the researchers who first described them [4][5]. These include:

  • DiGeorge Syndrome: Often used when heart defects and immune system issues were the primary findings [4].
  • Velocardiofacial Syndrome (VCFS): Also known as Shprintzen Syndrome, this name focused on palate (roof of the mouth) issues, heart defects, and specific facial features [4].
  • Conotruncal Anomaly Face Syndrome: Used primarily to describe certain heart and facial characteristics [6].

As genetic testing became more advanced, researchers discovered that all of these “different” syndromes were actually caused by the same underlying event: a small missing piece (microdeletion) on the 22nd chromosome at a location called q11.2 [6][7]. Today, the medical community uses the unified name 22q11.2 Deletion Syndrome to reflect this shared genetic cause [8].

Understanding the Frequency

22q11.2DS is more common than many people realize. It is the most frequent microdeletion syndrome in humans [9]. Current estimates suggest it occurs in approximately 1 in every 2,000 to 4,000 live births [9]. However, because the symptoms can be very mild in some people, many cases may go undiagnosed until adulthood [4][10].

The Rule of Variability

The most important thing to understand about 22q11.2DS is its phenotypic heterogeneity—a medical term meaning the symptoms vary wildly from person to person [11][4].

  • No two people are the same: Even within the same family, two people with the exact same deletion can have very different health challenges [12][13].
  • A wide spectrum: Some individuals may have significant heart or immune issues, while others may only have minor learning delays or speech difficulties [5][4].
  • Manageable care: Because doctors know which systems might be affected, they can use “anticipatory guidance” to monitor you or your child and treat issues early, often before they become serious [14][15].

Three Stabilizing Facts

  1. This is not your fault: Most cases (about 90%) occur “de novo,” meaning the deletion happened by chance and was not passed down by the parents or caused by anything anyone did [8].
  2. There is a roadmap for care: Because this condition is well-studied, there are established clinical guidelines for every stage of life [14][16]. Your “multidisciplinary team” will work together to support your specific needs [2][3].
  3. Knowledge is a tool: A diagnosis is not a ceiling on what a person can achieve; it is a tool that opens doors to specialized therapies, educational supports, and medical monitoring that help individuals reach their full potential [17][18].

Frequently Asked Questions

What is 22q11.2 Deletion Syndrome?
22q11.2 Deletion Syndrome is a genetic condition caused by a small missing piece of chromosome 22. It can affect various parts of the body, but symptoms and severity vary widely from person to person.
Is DiGeorge syndrome the same as 22q11.2 deletion syndrome?
Yes, DiGeorge syndrome is a historical name for 22q11.2 Deletion Syndrome. Medical professionals now use the unified name to reflect the shared genetic cause, which also includes Velocardiofacial Syndrome (VCFS).
Did I do something to cause my child's 22q11.2 deletion?
No, this condition is not your fault. In about 90% of cases, the deletion happens by chance and is not passed down by the parents or caused by anything you did before or during pregnancy.
How common is 22q11.2 Deletion Syndrome?
It is the most frequent microdeletion syndrome in humans, occurring in approximately 1 in every 2,000 to 4,000 live births. However, many mild cases may go undiagnosed until adulthood.

Questions for Your Doctor

  • • Based on my (or my child's) current symptoms, which manifestations of the syndrome should we be monitoring most closely right now?
  • • Are there local or national patient advocacy groups for 22q11.2DS that you recommend we join for support?
  • • Can you confirm whether the medical records reflect the unified name '22q11.2 Deletion Syndrome' to prevent confusion among my other specialists?

Questions for You

  • • What emotions am I experiencing right now, and do I have a supportive space to process the shock of this diagnosis?
  • • What are my biggest immediate fears about this diagnosis, and which specific facts from this guide help address them?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Birth Prevalence of Chromosome 22q11.2 Deletion Syndrome: A Systematic Review of Population-Based Studies.

    Panamonta V, Wichajarn K, Chaikitpinyo A, et al.

    Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2016; (99 Suppl 5()):S187-93.

    PMID: 29906080
  2. 2

    22q11.2 deletion - a tiny piece leading to a big picture.

    McDonald-McGinn DM

    Nature reviews. Disease primers 2020; (6(1)):33 doi:10.1038/s41572-020-0169-x.

    PMID: 32327654
  3. 3

    Healthcare Transition to Adulthood in Patients with 22q11.2 Deletion Syndrome: A Comprehensive Literature Review and Transition Framework.

    MacIsaac MF, Mattia A, Montes LA, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2025; 10556656251331392 doi:10.1177/10556656251331392.

    PMID: 40223294
  4. 4

    22q11.2 deletion syndrome.

    McDonald-McGinn DM, Sullivan KE, Marino B, et al.

    Nature reviews. Disease primers 2015; (1()):15071 doi:10.1038/nrdp.2015.71.

    PMID: 27189754
  5. 5

    Clinical characteristics and immunological status of patients with 22q11.2 deletion syndrome in Northern Thailand.

    Ua-Areechit T, Varnado P, Tengsujaritkul M, et al.

    Asian Pacific journal of allergy and immunology 2023; (41(1)):89-95 doi:10.12932/AP-241019-0671.

    PMID: 32416666
  6. 6

    Chromosome 22q11.2 deletion syndrome.

    Pereira E, Marion R

    Pediatrics in review 2015; (36(6)):270-2; discussion 272 doi:10.1542/pir.36-6-270.

    PMID: 26034260
  7. 7

    22q11.2 Deletion Syndrome Diagnosed 47 Years After Surgery for Tetralogy of Fallot.

    Harada Y, Kanazawa Y, Tobaru T, et al.

    Cureus 2023; (15(11)):e48206 doi:10.7759/cureus.48206.

    PMID: 38050519
  8. 8

    Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).

    Kuo CY, Signer R, Saitta SC

    Current allergy and asthma reports 2018; (18(12)):75 doi:10.1007/s11882-018-0823-5.

    PMID: 30377837
  9. 9

    Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening.

    Blagojevic C, Heung T, Theriault M, et al.

    CMAJ open 2021; (9(3)):E802-E809 doi:10.9778/cmajo.20200294.

    PMID: 34404688
  10. 10

    Variability in Neuropsychological Phenotypes in Patients with 22Q11.2 Deletion Syndrome: Case Series.

    Wierzchowski A, Sablich-Duley S, Bordes Edgar V

    Developmental neuropsychology 2021; (46(5)):381-392 doi:10.1080/87565641.2021.1956498.

    PMID: 34311629
  11. 11

    Candidate modifier genes for immune function in 22q11.2 deletion syndrome.

    Pinnaro CT, Henry T, Major HJ, et al.

    Molecular genetics & genomic medicine 2020; (8(1)):e1057 doi:10.1002/mgg3.1057.

    PMID: 31830774
  12. 12

    Pathogenic variants in CDC45 on the remaining allele in patients with a chromosome 22q11.2 deletion result in a novel autosomal recessive condition.

    Unolt M, Kammoun M, Nowakowska B, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(2)):326-335 doi:10.1038/s41436-019-0645-4.

    PMID: 31474763
  13. 13

    Contribution of schizophrenia polygenic burden to longitudinal phenotypic variance in 22q11.2 deletion syndrome.

    Alver M, Mancini V, Läll K, et al.

    Molecular psychiatry 2022; (27(10)):4191-4200 doi:10.1038/s41380-022-01674-9.

    PMID: 35768638
  14. 14

    Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome.

    Óskarsdóttir S, Boot E, Crowley TB, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(3)):100338 doi:10.1016/j.gim.2022.11.006.

    PMID: 36729053
  15. 15

    Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.

    Lin HY, Tsai WY, Tung YC, et al.

    Frontiers in endocrinology 2022; (13()):771100 doi:10.3389/fendo.2022.771100.

    PMID: 35432203
  16. 16

    Surgical insights and management in patients with the 22q11.2 deletion syndrome.

    McGovern PE, Crowley TB, Zackai EH, et al.

    Pediatric surgery international 2022; (38(6)):899-905 doi:10.1007/s00383-022-05123-0.

    PMID: 35411495
  17. 17

    Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.

    Schindewolf E, Khalek N, Johnson MP, et al.

    American journal of medical genetics. Part A 2018; (176(8)):1735-1741 doi:10.1002/ajmg.a.38665.

    PMID: 30055034
  18. 18

    Hearing loss and history of otolaryngological conditions in adults with microdeletion 22q11.2.

    von Scheibler ENMM, Widdershoven JCC, van Barneveld DCPBM, et al.

    American journal of medical genetics. Part A 2024; (194(3)):e63456 doi:10.1002/ajmg.a.63456.

    PMID: 37916923

This page provides a general overview of 22q11.2 Deletion Syndrome for educational purposes. Always consult your multidisciplinary healthcare team for personalized medical advice and care planning.

Stay up to date

Get notified when new research about 22q11.2 deletion syndrome is published.

No spam. Unsubscribe anytime.